A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza
Status:
Completed
Trial end date:
2017-04-24
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of a single, oral dose of
baloxavir marboxil compared with placebo by measuring the time to alleviation of symptoms in
patients with uncomplicated influenza virus infection.